about
Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarctionAdenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarctionVasodilators in the treatment of patients with acute myocardial infarction undergoing percutaneous coronary interventionNo reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarctionNo-Reflow Phoenomenon by Intracoronary Thrombus in Acute Myocardial InfarctionRole of cardiovascular magnetic resonance in acute coronary syndromeMagnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologiesSpontaneous and procedural plaque embolisation in native coronary arteries: pathophysiology, diagnosis, and preventionIntracoronary Near-Infrared Spectroscopy (NIRS) Imaging for Detection of Lipid Content of Coronary Plaques: Current Experience and Future PerspectivesPeripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptidesIntramyocardial hemorrhage: an enigma for cardiac MRI?No reflow leading to catastrophic hemodynamic collapse in a patient with severe aortic stenosis and its management.Manual Thrombus Aspiration and the Improved Survival of Patients With Unstable Angina Pectoris Treated With Percutaneous Coronary Intervention (30 Months Follow-Up)Acute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function.Cardiovascular magnetic resonance imaging of myocardial infarction, viability, and cardiomyopathies.Diagnostic ultrasound induced inertial cavitation to non-invasively restore coronary and microvascular flow in acute myocardial infarction.Cardiac magnetic resonance imaging in ischemic heart disease: a clinical review.Therapeutic application of ultrasound: contrast-enhanced thrombolysis in acute ST-elevation myocardial infarction; the Sonolysis studyNonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon.A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI)Predictors and outcome of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarctionHeart failure after myocardial infarction in the era of primary percutaneous coronary intervention: Mechanisms, incidence and identification of patients at riskIntracoronary delivery of bone-marrow-derived stem cells.Suppression of NF-κB reduces myocardial no-reflow.Predicting coronary no-reflow in patients with acute ST-segment elevation myocardial infarction using Bayesian approaches.Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure.Coronary microvascular dysfunction: an updateMeta-analysis of randomized controlled trials on the efficacy and safety of intracoronary administration of tirofiban for no-reflow phenomenon.Non-invasive evaluation of myocardial reperfusion by transthoracic Doppler echocardiography and single-photon emission computed tomography in patients with anterior acute myocardial infarction.Cardiovascular remodelling in coronary artery disease and heart failure.High tenascin-C levels cause inadequate myocardial blush grade in patients with acute myocardial infarctionThe role of von Willebrand factor and ADAMTS13 in the no-reflow phenomenon: after primary percutaneous coronary interventionCoronary and microvascular thrombolysis with guided diagnostic ultrasound and microbubbles in acute ST segment elevation myocardial infarctionRecent advances in the diagnosis and treatment of acute myocardial infarctionNo-Reflow Phenomenon in Central Retinal Artery Occlusion: Incidence, Risk Factors, and Clinical ImplicationsThrombus aspiration during primary percutaneous coronary intervention is associated with reduced myocardial edema, hemorrhage, microvascular obstruction and left ventricular remodelingClinical and Angiographic Predictors of Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction.Impact of thrombus aspiration during ST-Elevation Myocardial Infarction: a six month composite endpoint and risk of stroke analyses of the TASTE trial.Vagal nerve stimulation started just prior to reperfusion limits infarct size and no-reflowHow does coronary stent implantation impact on the status of the microcirculation during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction?
P2860
Q24187926-5529FC60-AD5A-44C6-BFDB-2A2C800AD5A5Q24202298-2A93662F-0231-4DE1-AA9C-4DB54913B14CQ24234883-73293881-4042-4E88-8DF1-D2AE8CD2ECC9Q26740252-28DB119B-1DD9-4819-A4FF-1588A82A3142Q26766631-EE697072-2EDC-403F-A50D-B12931C5CAD1Q26771326-78FFCD8B-DFC5-490B-8DAC-D7B2A9F059CAQ26824231-A58CB71F-B7F2-44FE-A993-A982E7D4B23BQ26828732-CA1B4233-916E-49A9-98CC-F27D96B10FB2Q26992156-44686BAF-E16C-45E8-86D6-C166D7FD652CQ27026280-30A26913-6F63-4B48-8534-293D745126A4Q28082737-A43C4C78-09E2-46DD-AAA5-22022147245CQ30151097-528E469F-8AEF-44E6-BF31-C5DF6B9135AFQ30387755-FEE74E78-5984-41E1-BDB5-8769B936E700Q30425798-CD9463B5-2CA1-45A5-A193-1BA41ABF64EDQ30432814-049CF264-5759-4C5A-A143-3ABCF7723E7AQ30451224-B1EF635B-ECD9-4BB6-AF33-9E68255D3634Q30468452-19EC3706-71E7-434F-B028-A8F9EFF556A9Q30475961-0056B423-DA85-4413-8E2F-B72BD1083FA9Q30583012-1B0C3CD4-6681-4A0E-B1F7-4BC7FD9A804CQ33642159-E8D5DF3C-DD2B-4D05-94DC-7ABD064F50B8Q33718246-54C728A8-690F-4A57-9841-2383AC04E06AQ33721171-483A1913-19EB-41DB-A7A4-1D17926463E5Q34318046-10898F88-4FEA-41E8-B39B-F527217F3DA2Q34442981-C6E7B765-4EC2-423E-8085-F195FBA1F890Q34463125-5555726C-CDD5-4F27-97AA-B38807CE9141Q34498176-01482C51-348D-45CC-85D1-F40746C5E58CQ34658569-AF7BE7A0-6612-42B5-9E00-7868AEDC3DCBQ34982030-7B1F40CF-4272-41D0-95BF-E240C8EBE431Q35068344-7177B25F-1BCE-44A2-AB41-036BE704FDAEQ35090566-DD703713-F362-4AB7-A41C-2FBDABAE93DEQ35480748-669C7975-8741-46D3-86C4-7A8D94534192Q35594787-05C0CB44-C7CC-49DF-80D6-42A97AF752E2Q35608036-1AAEBEC3-F4C5-4799-878E-F8CFA49EB7C5Q35626702-AACDFBEA-95FB-4B97-9BE5-D26A67DE2DDAQ35850184-7FF68115-831D-4D4C-88CD-4D720FFBE447Q35887746-25FC8829-3541-4196-B891-CC99BC8E4A87Q35971039-2B130D8F-697B-413B-B093-84E40EC6992CQ35977146-197296AD-F072-4674-A130-3951D9E4B9D4Q35995878-25ADAF06-61CF-461D-BE32-FC83BB7CDDE5Q36333233-01821855-D3D1-4AD2-939A-42D2FA57F583
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Myocardial no-reflow in humans.
@en
Myocardial no-reflow in humans.
@nl
type
label
Myocardial no-reflow in humans.
@en
Myocardial no-reflow in humans.
@nl
prefLabel
Myocardial no-reflow in humans.
@en
Myocardial no-reflow in humans.
@nl
P2093
P1476
Myocardial no-reflow in humans.
@en
P2093
Filippo Crea
Francesco Burzotta
Giampaolo Niccoli
Leonarda Galiuto
P304
P356
10.1016/J.JACC.2009.03.054
P407
P577
2009-07-01T00:00:00Z